How dangerous are India’s generic drugs? Very


India relies on the weak oversight of developing countries that make up the bulk of its exports – that’s how it can continue to push substandard and often deadly medicines there. — Bloomberg

FOR a nation that seeks to claim the mantle of “pharmacy to the world,” India is scandalously short on regulatory oversight.

In the last six months, its generic cough syrups have killed dozens of children, its eye drops have caused blindness and its chemotherapy drugs have been contaminated.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
India , genericdrugs , regulation , oversight , scandals

Next In Business News

Traders start 2026 by locking in gains
Ringgit starts 2026 firmer on weaker greenback
Sarawak complete acquisition of MASwings
Trading ideas: Capital A, Axis REIT, LFE, Camaroe, NCT, CJ Century, TSH, BAT, Berjaya Assts, MSC, SE Resources
European stocks clinch best year since 2021�
Xi promises more proactive macro policies
Gold futures end 2025 easier, in sync with Comex�
Berjaya Assets appoints Vincent Tan’s son-in-law as new CEO
Washington approves TSMC chip shipments to China
Oyo Hotels’ parent files confidential IPO in India

Others Also Read